— Know what they know.
/
Not Investment Advice

RPRX NASDAQ

Royalty Pharma plc
1W: -1.8% 1M: -9.4% 3M: +0.4% YTD: +47.9% 1Y: +58.2% 3Y: +127.9% 5Y: +70.8%
$57.16
-0.47 (-0.82%)
 
Weekly Expected Move ±3.2%
$53 $55 $57 $59 $61
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 40 · $25.3B mcap · 415M float · 0.803% daily turnover · Short 44% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
57.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 10.6%  ·  5Y Avg: 6.1%
Cost Advantage
64
Intangibles
43
Switching Cost
44
Network Effect
70
Scale ★
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. RPRX has a Narrow competitive edge (57.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 10.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$65
Low
$66
Avg Target
$66
High
Based on 2 analysts since Aug 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$65.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-06 Goldman Sachs — $42 $66 +24 +15.7% $57.02
2026-08-06 Morgan Stanley — $63 $65 +2 +12.6% $57.75
2026-04-21 UBS Ashwani Verma $49 $57 +8 +15.6% $49.30
2026-04-10 Morgan Stanley Terence Flynn $61 $63 +2 +31.3% $47.98
2026-02-27 Seaport Global — Initiated $50 — +8.2% $46.21
2026-02-12 Morgan Stanley Terence Flynn $54 $61 +7 +36.4% $44.71
2026-01-30 UBS Ashwani Verma $28 $49 +21 +19.9% $40.86
2025-12-11 Leerink Partners — Initiated $45 — +17.7% $38.22
2025-09-30 Goldman Sachs — $51 $42 -9 +19.1% $35.25
2025-07-10 Morgan Stanley Terence Flynn $51 $54 +3 +49.4% $36.14
2024-09-04 Goldman Sachs Chris Shibutani $50 $51 +1 +74.9% $29.16
2024-07-11 Morgan Stanley Terence Flynn $51 $51 0 +98.2% $25.73
2024-06-07 Goldman Sachs Chris Shibutani Initiated $50 — +84.6% $27.09
2024-06-03 UBS Ashwani Verma $47 $28 -19 +2.4% $27.35
2022-12-06 Morgan Stanley — Initiated $51 — +19.0% $42.87
2022-06-13 UBS Ashwani Verma Initiated $47 — +22.2% $38.46

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
5
ROE
4
ROA
5
D/E
1
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. RPRX receives an overall rating of B+. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-09-09 B B+
2026-09-03 B+ B
2026-08-10 B B+
2026-08-06 B- B
2026-08-05 B+ B-
2026-05-11 B- B+
2026-05-06 A- B-
2026-04-01 B+ A-
2026-02-18 B- B+
2026-02-11 B+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 55 Grade B
Profitability
46
Balance Sheet
42
Earnings Quality
52
Growth
33
Value
42
Momentum
64
Safety
50
Cash Flow
85
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. RPRX scores highest in Cash Flow (85/100) and lowest in Growth (33/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.46
Grey Zone
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✗ ✓ ✓ ✗ ✓
Beneish M-Score
21.99
Possible Manipulator
Ohlson O-Score
-8.45
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB-
Score: 54.1/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 3.65x
Accruals: -11.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. RPRX scores 2.46, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. RPRX scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. RPRX's score of 21.99 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. RPRX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. RPRX receives an estimated rating of BBB- (score: 54.1/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). RPRX's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
23.71x
PEG
6.91x
P/S
9.99x
P/B
3.72x
P/FCF
10.49x
P/OCF
10.49x
EV/EBITDA
22.93x
EV/Revenue
15.52x
EV/EBIT
23.00x
EV/FCF
13.22x
Earnings Yield
2.61%
FCF Yield
9.53%
Shareholder Yield
2.31%
Graham Number
$20.10
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 23.7x earnings, RPRX commands a growth premium. Graham's intrinsic value formula yields $20.10 per share, 184% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.604
NI / EBT
×
Interest Burden
0.789
EBT / EBIT
×
EBIT Margin
0.675
EBIT / Rev
×
Asset Turnover
0.133
Rev / Assets
×
Equity Multiplier
2.894
Assets / Equity
=
ROE
12.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. RPRX's ROE of 12.4% is driven by a balanced combination of operating margin, asset efficiency, and leverage.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$56.36
Price/Value
0.99x
Margin of Safety
0.52%
Premium
-0.52%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with RPRX's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. RPRX actually compounded EPS at 51.5% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. RPRX trades at a -1% premium to its adjusted intrinsic value of $56.36, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 23.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1583 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$57.16
Median 1Y
$58.55
5th Pctile
$38.73
95th Pctile
$88.53
Ann. Volatility
26.7%
Analyst Target
$65.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Christopher Hite &
xecutive Vice President & Vice Chairman
 $1,323,000 $— $1,323,000
Marshall Urist, M.D.,
Ph.D. Executive Vice President, Research & Investments
 $1,323,000 $— $1,323,000
George Lloyd Advisor;
dvisor; former Executive Vice President, Chief Legal Officer & Investments
 $1,323,000 $— $1,323,000
Terrance Coyne &
xecutive Vice President & Chief Financial Officer
 $1,323,000 $— $1,323,000
Pablo Legorreta
Chief Executive Officer
 $937,500 $— $937,500

CEO Pay Ratio

0:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $937,500
Avg Employee Cost (SGA/emp): $5,734,810
Employees: 100

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
100
+1.0% YoY
Revenue / Employee
$23,781,930
Rev: $2,378,193,000
Profit / Employee
$7,709,470
NI: $770,947,000
SGA / Employee
$5,734,810
Avg labor cost proxy
R&D / Employee
$4,520,000
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 15.3% 11.7% 11.3% 7.9% 8.5% 0.8% 5.7% 4.1% 3.0% 18.7% 12.8% 10.6% 17.6% 12.8% 16.6% 15.9% 11.5% 11.5% 12.2% 12.4% 12.37%
ROA 4.6% 3.7% 3.6% 2.7% 2.9% 0.2% 1.9% 1.5% 1.1% 6.8% 4.8% 3.9% 6.8% 5.0% 6.5% 5.7% 4.1% 4.1% 4.4% 4.3% 4.27%
ROIC 15.6% 14.2% 14.3% 10.8% 8.5% 3.0% 5.4% 4.2% 3.7% 13.1% 8.5% 8.3% 12.1% 10.1% 15.2% 14.3% 10.6% 10.5% 10.9% 10.6% 10.57%
ROCE 10.0% 8.8% 8.8% 6.0% 5.7% 5.9% 7.4% 6.6% 6.4% 10.1% 7.5% 6.9% 11.4% 9.2% 12.3% 11.3% 8.4% 8.6% 8.8% 8.9% 8.92%
Gross Margin 76.5% 53.7% 67.2% 80.3% 46.8% 45.4% 82.6% 55.2% 48.3% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 99.8% 60.2% 60.21%
Operating Margin 51.7% 26.6% 39.1% 70.5% 33.5% -85.3% 70.0% 46.2% 28.2% 1.0% -13.0% 50.2% 1.3% 60.9% 94.0% 36.3% 70.1% 62.4% 1.0% 19.7% 19.73%
Net Margin 17.4% 1.4% 9.2% 56.8% 24.9% -80.6% 49.8% 42.3% 13.4% 82.9% 0.8% 19.0% 96.3% 35.1% 41.9% 5.2% 47.3% 34.4% 46.8% 2.7% 2.65%
EBITDA Margin 52.7% 27.7% 40.1% 70.5% 33.5% 23.5% 70.2% 46.5% 28.5% 1.3% 7.0% 45.3% 1.5% 67.4% 87.8% 27.5% 86.2% 72.6% 89.3% 26.2% 26.17%
FCF Margin 91.6% 88.1% 85.7% 88.3% 91.8% 95.8% 1.2% 1.2% 1.2% 1.3% 1.2% 1.2% 1.2% 1.2% 1.2% 1.1% 1.1% 1.1% 1.1% 1.2% 1.17%
OCF Margin 91.6% 88.1% 85.7% 88.3% 91.8% 95.8% 1.2% 1.2% 1.2% 1.3% 1.2% 1.2% 1.2% 1.2% 1.2% 1.1% 1.1% 1.1% 1.1% 1.2% 1.17%
ROE 3Y Avg snapshot only 12.80%
ROE 5Y Avg snapshot only 10.04%
ROA 3Y Avg snapshot only 4.50%
ROIC 3Y Avg snapshot only 8.00%
ROIC Economic snapshot only 10.04%
Cash ROA snapshot only 15.02%
Cash ROIC snapshot only 19.90%
CROIC snapshot only 19.90%
NOPAT Margin snapshot only 62.34%
Pretax Margin snapshot only 53.23%
R&D / Revenue snapshot only 9.44%
SGA / Revenue snapshot only 23.81%
SBC / Revenue snapshot only 7.83%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 25.28 29.76 35.73 50.07 44.20 444.73 61.14 68.16 83.09 10.46 21.65 22.45 14.17 17.06 16.17 19.61 25.66 28.05 32.44 38.30 23.714
P/S Ratio 8.66 8.06 9.45 10.33 9.97 8.51 8.60 7.36 6.59 5.04 7.73 6.75 7.16 6.47 7.81 8.68 8.35 9.09 11.00 12.31 9.991
P/B Ratio 3.42 3.19 3.73 3.87 3.64 3.38 3.41 2.77 2.50 1.82 2.66 2.33 2.36 2.11 2.64 3.15 3.06 3.34 3.90 4.57 3.723
P/FCF 9.46 9.14 11.03 11.70 10.85 8.88 7.47 6.32 5.50 3.97 6.61 5.66 5.80 5.29 6.54 8.11 7.95 8.47 9.88 10.49 10.491
P/OCF 9.46 9.14 11.03 11.70 10.85 8.88 7.47 6.32 5.50 3.97 6.61 5.66 5.80 5.29 6.54 8.11 7.95 8.47 9.88 10.49 10.491
EV/EBITDA 13.60 14.64 16.66 25.24 28.59 25.56 20.97 20.45 19.45 10.17 18.13 16.79 11.49 13.17 11.65 13.74 17.46 18.32 20.72 22.93 22.933
EV/Revenue 10.58 9.93 11.29 11.97 12.15 10.61 10.52 9.14 8.51 7.12 9.78 9.01 9.74 9.05 10.37 11.51 11.76 12.59 14.42 15.52 15.517
EV/EBIT 13.78 14.86 16.91 25.66 28.94 25.72 21.00 20.50 19.53 10.20 18.18 16.81 11.49 13.17 11.65 13.74 17.47 18.35 20.76 23.00 22.999
EV/FCF 11.56 11.27 13.18 13.55 13.22 11.07 9.13 7.85 7.10 5.61 8.36 7.55 7.89 7.40 8.69 10.75 11.20 11.73 12.95 13.22 13.220
Earnings Yield 4.0% 3.4% 2.8% 2.0% 2.3% 0.2% 1.6% 1.5% 1.2% 9.6% 4.6% 4.5% 7.1% 5.9% 6.2% 5.1% 3.9% 3.6% 3.1% 2.6% 2.61%
FCF Yield 10.6% 10.9% 9.1% 8.5% 9.2% 11.3% 13.4% 15.8% 18.2% 25.2% 15.1% 17.7% 17.2% 18.9% 15.3% 12.3% 12.6% 11.8% 10.1% 9.5% 9.53%
PEG Ratio snapshot only 6.907
Price/Tangible Book snapshot only 5.284
EV/OCF snapshot only 13.220
EV/Gross Profit snapshot only 17.361
Acquirers Multiple snapshot only 24.889
Shareholder Yield snapshot only 2.31%
Graham Number snapshot only $20.10
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 10.88 16.81 21.95 19.22 2.07 2.19 2.36 2.52 13.51 7.90 12.52 9.35 1.54 1.44 1.56 1.26 3.48 0.97 2.66 1.29 1.287
Quick Ratio 10.88 16.81 21.95 19.22 2.07 2.19 2.36 2.52 13.51 7.90 12.52 9.35 1.54 1.44 1.56 1.26 3.48 0.97 2.66 1.29 1.287
Debt/Equity 1.22 1.23 1.23 1.18 1.16 1.26 1.20 1.13 1.00 0.94 0.94 1.17 1.11 1.10 1.14 1.26 1.40 1.38 1.30 1.31 1.312
Net Debt/Equity 0.76 0.74 0.73 0.61 0.80 0.83 0.76 0.67 0.72 0.75 0.71 0.78 0.85 0.84 0.87 1.03 1.25 1.28 1.21 1.19 1.189
Debt/Assets 0.40 0.41 0.41 0.40 0.40 0.42 0.42 0.42 0.39 0.37 0.38 0.43 0.42 0.42 0.43 0.44 0.46 0.46 0.45 0.45 0.452
Debt/EBITDA 3.99 4.57 4.60 6.63 7.45 7.66 6.02 6.75 6.03 3.72 5.08 6.33 3.96 4.89 3.78 4.14 5.66 5.48 5.27 5.22 5.223
Net Debt/EBITDA 2.47 2.76 2.71 3.46 5.13 5.05 3.83 3.99 4.37 2.97 3.81 4.20 3.04 3.75 2.88 3.37 5.06 5.09 4.91 4.74 4.735
Interest Coverage 11.18 9.21 8.65 5.69 5.02 4.91 6.29 5.61 5.42 8.78 6.53 6.43 9.28 6.90 8.17 7.25 5.66 5.30 5.04 4.74 4.738
Equity Multiplier 3.06 3.03 3.01 2.94 2.87 2.99 2.87 2.73 2.58 2.51 2.48 2.73 2.63 2.62 2.63 2.89 3.02 3.03 2.88 2.90 2.901
Cash Ratio snapshot only 1.327
Debt Service Coverage snapshot only 4.752
Cash to Debt snapshot only 0.093
FCF to Debt snapshot only 0.332
Defensive Interval snapshot only 919.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.14 0.14 0.14 0.13 0.13 0.13 0.14 0.14 0.14 0.14 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.133
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 41.46 42.60 43.07 56.36 41.48 42.65 45.26 66.92 63.89 79.81 73.80 76.10 72.15 91.72 98.40 89.83 5.14 5.22 5.87 5.53 5.530
Payables Turnover 33.32 84.98 78.88 64.42 68.14 133.70 125.90 108.31 63.62 55.24 56.94 18.97 0.00 0.00 0.00 0.00 0.00 0.00 0.04 9.66 9.660
DSO 9 9 8 6 9 9 8 5 6 5 5 5 5 4 4 4 71 70 62 66 66.0 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 — — — — — — 0 0 0.0 days
DPO 11 4 5 6 5 3 3 3 6 7 6 19 — — — — — — 9836 38 37.8 days
Cash Conversion Cycle -2 4 4 1 3 6 5 2 -0 -2 -1 -14 — — — — — — -9774 28 28.2 days
Cash Velocity snapshot only 3.030
Capital Intensity snapshot only 7.815
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 1.2% 41.2% 3.8% 0.9% -1.7% -2.3% 3.5% 4.5% 3.4% 5.2% -5.1% -5.2% -2.5% -3.9% 1.1% 3.0% 3.7% 5.1% 7.8% 10.0% 10.01%
Net Income 6.9% -31.4% -38.1% -52.0% -35.3% -93.1% -44.9% -45.3% -63.6% 25.5% 1.4% 1.6% 5.2% -24.3% 36.8% 51.6% -33.2% -10.2% -24.3% -20.1% -20.12%
EPS -34.9% -47.9% -38.1% -52.0% -35.3% -93.2% -44.9% -45.2% -63.2% 30.0% 1.4% 1.7% 5.3% -42.6% 41.4% 61.0% -29.2% -5.5% -21.8% -19.4% -19.39%
FCF 1.1% 29.0% -6.6% -6.4% -1.4% 6.3% 39.2% 37.9% 34.9% 39.4% -3.6% -3.0% 0.5% -7.3% 3.1% -7.5% -11.8% -7.8% 0.6% 20.5% 20.54%
EBITDA 36.5% -8.0% -19.8% -49.7% -46.3% -40.2% -23.3% -1.4% 6.5% 77.5% 2.1% 13.7% 89.0% -5.6% 66.8% 60.8% -17.6% 5.0% -15.7% -11.1% -11.14%
Op. Income 73.0% 15.9% -2.9% -41.4% -40.7% -78.5% -60.2% -58.5% -57.9% 3.9% 65.9% 1.2% 2.9% -13.4% 1.0% 91.7% -0.7% 20.7% -12.8% -14.1% -14.10%
OCF Growth snapshot only 20.54%
Asset Growth snapshot only 8.17%
Equity Growth snapshot only 7.64%
Debt Growth snapshot only 11.99%
Shares Change snapshot only -0.91%
Dividend Growth snapshot only 7.02%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — 66.6% 30.4% 13.2% 0.7% -0.0% -0.3% -0.4% -0.2% 0.7% 1.5% 2.1% 1.1% 2.4% 2.41%
Revenue 5Y — — — — — — — — — — — — — — — 35.2% 17.5% 8.0% 2.1% 2.5% 2.53%
EPS 3Y — — — — — — — -30.4% -46.3% 3.0% -5.9% -11.0% 14.4% 6.3% 24.0% 33.3% 17.9% 1.6% 39.4% 51.5% 51.53%
EPS 5Y — — — — — — — — — — — — — — — 7.8% -7.1% -10.0% -1.6% -1.8% -1.76%
Net Income 3Y — — — — — — — -16.8% -36.9% 7.9% -6.4% -11.5% 13.5% 11.5% 22.0% 29.9% 14.7% 1.6% 35.6% 47.3% 47.33%
Net Income 5Y — — — — — — — — — — — — — — — 18.2% 0.9% -3.1% -3.2% -3.4% -3.45%
EBITDA 3Y — — — — — — — 18.1% -7.9% -0.8% -14.4% -17.4% 2.6% 0.1% 9.3% 21.7% 18.4% 20.7% 12.8% 17.6% 17.56%
EBITDA 5Y — — — — — — — — — — — — — — — 24.6% 4.0% -0.6% -2.5% -4.2% -4.24%
Gross Profit 3Y — — — — — — — 39.5% 9.5% 4.8% -1.0% 2.6% 9.5% 12.4% 10.2% 13.8% 19.3% 21.3% 17.1% 17.8% 17.78%
Gross Profit 5Y — — — — — — — — — — — — — — — 35.2% 17.5% 9.8% 6.6% 4.5% 4.52%
Op. Income 3Y — — — — — — — 2.2% -24.5% 6.5% -13.7% -18.9% -1.0% -3.3% 10.2% 20.4% 17.6% 71.9% 43.1% 53.5% 53.47%
Op. Income 5Y — — — — — — — — — — — — — — — 35.1% 10.7% 4.8% 2.5% -2.5% -2.55%
FCF 3Y — — — — — — — 77.8% 40.8% 24.1% 7.8% 7.8% 10.2% 11.1% 11.4% 7.4% 6.1% 6.0% -0.0% 2.7% 2.67%
FCF 5Y — — — — — — — — — — — — — — — 38.2% 19.9% 10.3% 5.4% 6.9% 6.90%
OCF 3Y — — — — — — — 77.8% 40.8% 24.1% 7.8% 7.8% 10.2% 11.1% 11.4% 7.4% 6.1% 6.0% -0.0% 2.7% 2.67%
OCF 5Y — — — — — — — — — — — — — — — 38.2% 19.9% 10.3% 5.4% 6.9% 6.90%
Assets 3Y — — — — — — — 3.0% -0.3% 0.7% 0.5% 2.3% 0.6% 1.3% 0.4% 1.1% 3.1% 5.3% 5.1% 5.0% 5.00%
Assets 5Y — — — — — — — — — — — — — — — 3.2% 3.9% 4.1% 4.5% 3.7% 3.72%
Equity 3Y — — — — — — — 14.8% 11.3% 10.6% 10.0% 4.1% 5.8% 6.3% 5.0% 1.7% 1.4% 4.8% 5.0% 2.8% 2.84%
Book Value 3Y — — — — — — — -4.1% -5.3% 5.6% 10.6% 4.7% 6.7% 1.4% 6.7% 4.4% 4.2% 2.4% 7.9% 5.8% 5.77%
Dividend 3Y — — — — — — — -13.4% -12.3% -2.2% 2.8% 2.5% 2.6% -3.0% 3.0% 3.4% 3.3% -2.1% 3.6% 4.9% 4.88%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — 0.76 0.73 0.69 1.00 0.65 0.62 0.67 0.15 0.05 0.00 0.01 0.17 0.66 0.71 0.75 0.43 0.45 0.450
Earnings Stability — — — 0.00 0.59 0.96 0.99 0.20 0.83 0.00 0.14 0.02 0.01 0.03 0.05 0.10 0.02 0.03 0.06 0.05 0.054
Margin Stability — — — 0.81 0.75 0.77 0.89 0.77 0.75 0.82 0.91 0.83 0.75 0.77 0.81 0.78 0.74 0.79 0.82 0.82 0.816
Rev. Growth Consistency 0.50 0.50 0.50 1.00 0.00 0.00 1.00 1.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — — — 0.50 0.86 0.50 0.82 0.82 0.50 0.50 0.50 0.50 0.50 0.90 0.85 0.50 0.87 0.96 0.90 0.92 0.920
Earnings Smoothness 0.93 0.63 0.53 0.30 0.57 0.00 0.42 0.41 0.07 0.00 0.17 0.10 0.00 0.72 0.69 0.59 0.60 0.89 0.72 0.78 0.776
ROE Trend — — — -0.06 -0.07 -0.14 -0.10 -0.08 -0.08 0.12 0.04 0.04 0.11 0.03 0.07 0.09 0.02 -0.03 -0.02 -0.01 -0.013
Gross Margin Trend — — — -0.21 -0.26 -0.21 -0.13 -0.16 -0.09 0.08 0.08 0.24 0.40 0.34 0.29 0.27 0.20 0.14 0.12 -0.04 -0.044
FCF Margin Trend — — — -0.07 -0.01 0.04 0.25 0.25 0.28 0.35 0.17 0.17 0.18 0.11 0.03 -0.11 -0.17 -0.17 -0.07 0.04 0.042
Sustainable Growth Rate 10.0% 6.3% 5.6% 2.6% 3.1% -5.1% -0.1% -1.5% -2.7% 12.8% 7.0% 4.8% 11.9% 7.2% 10.8% 10.0% 5.8% 5.9% 6.5% 6.3% 6.32%
Internal Growth Rate 3.1% 2.0% 1.8% 0.9% 1.1% — — — — 4.9% 2.7% 1.8% 4.8% 2.9% 4.4% 3.7% 2.1% 2.1% 2.4% 2.2% 2.23%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.67 3.26 3.24 4.28 4.07 50.06 8.19 10.79 15.10 2.63 3.28 3.96 2.44 3.22 2.47 2.42 3.23 3.31 3.28 3.65 3.651
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 3.651
OCF/EBITDA snapshot only 1.735
CapEx/Revenue 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.08 -0.08 -0.08 -0.09 -0.09 -0.12 -0.14 -0.14 -0.16 -0.11 -0.11 -0.11 -0.10 -0.11 -0.10 -0.08 -0.09 -0.09 -0.10 -0.11 -0.113
Sloan Accruals snapshot only -0.007
Cash Flow Adequacy snapshot only 7.459
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 1.4% 1.5% 1.4% 1.3% 1.4% 1.7% 1.7% 2.0% 2.3% 3.0% 2.1% 2.4% 2.3% 2.6% 2.1% 1.9% 1.9% 1.7% 1.4% 1.3% 1.62%
Dividend/Share $0.44 $0.56 $0.50 $0.51 $0.53 $0.64 $0.56 $0.57 $0.59 $0.80 $0.61 $0.62 $0.63 $0.64 $0.65 $0.67 $0.67 $0.68 $0.69 $0.72 $0.93
Payout Ratio 34.4% 46.0% 50.0% 66.9% 63.7% 7.8% 1.0% 1.4% 1.9% 31.6% 45.5% 54.6% 32.5% 43.8% 34.6% 36.9% 49.4% 49.1% 46.8% 48.9% 48.95%
FCF Payout Ratio 12.9% 14.1% 15.4% 15.6% 15.6% 15.5% 12.5% 12.6% 12.7% 12.0% 13.9% 13.8% 13.3% 13.6% 14.0% 15.2% 15.3% 14.8% 14.3% 13.4% 13.41%
Total Payout Ratio 34.4% 46.0% 50.0% 66.9% 63.7% 7.8% 1.0% 1.4% 2.7% 46.6% 66.8% 91.8% 50.6% 70.6% 1.2% 1.5% 2.1% 2.1% 1.2% 88.4% 88.41%
Div. Increase Streak 1 1 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.37 0.13 -0.05 0.26 0.21 0.19 0.14 0.13 0.12 0.11 0.09 0.08 0.08 0.08 0.06 0.04 0.03 0.02 0.04 0.07 0.073
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.9% 1.4% 1.0% 1.7% 1.3% 1.6% 5.3% 5.7% 6.1% 5.7% 2.1% 1.0% 1.03%
Net Buyback Yield -0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.9% 1.4% 1.0% 1.7% 1.3% 1.6% 5.3% 5.7% 6.1% 5.7% 2.1% 1.0% 1.03%
Total Shareholder Return 1.4% 1.5% 1.4% 1.3% 1.4% 1.7% 1.7% 2.0% 3.2% 4.5% 3.1% 4.1% 3.6% 4.1% 7.5% 7.6% 8.0% 7.4% 3.6% 2.3% 2.31%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.50 0.50 0.50 0.52 0.57 0.19 0.54 0.54 0.50 0.67 0.67 0.65 0.67 0.65 0.62 0.61 0.59 0.58 0.61 0.60 0.604
Interest Burden (EBT/EBIT) 0.89 0.81 0.80 0.85 0.95 0.25 0.52 0.45 0.37 1.03 0.98 0.86 0.89 0.86 0.88 0.86 0.82 0.81 0.80 0.79 0.789
EBIT Margin 0.77 0.67 0.67 0.47 0.42 0.41 0.50 0.45 0.44 0.70 0.54 0.54 0.85 0.69 0.89 0.84 0.67 0.69 0.69 0.67 0.675
Asset Turnover 0.14 0.14 0.14 0.13 0.13 0.13 0.14 0.14 0.14 0.14 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.13 0.133
Equity Multiplier 3.29 3.17 3.12 2.91 2.96 3.01 2.94 2.83 2.73 2.73 2.67 2.73 2.61 2.57 2.56 2.81 2.81 2.82 2.76 2.89 2.894
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $1.29 $1.21 $0.99 $0.77 $0.83 $0.08 $0.55 $0.42 $0.31 $2.54 $1.34 $1.13 $1.93 $1.46 $1.89 $1.82 $1.37 $1.38 $1.48 $1.46 $1.46
Book Value/Share $9.54 $11.30 $9.52 $9.93 $10.13 $10.77 $9.80 $10.37 $10.21 $14.61 $10.88 $10.85 $11.58 $11.79 $11.57 $11.30 $11.46 $11.57 $12.31 $12.27 $21.99
Tangible Book/Share $9.52 $11.29 $9.52 $9.93 $10.13 $10.77 $9.80 $10.37 $10.21 $14.61 $10.88 $10.85 $11.58 $-13.89 $11.57 $9.65 $9.80 $9.92 $-18.90 $10.61 $10.61
Revenue/Share $3.76 $4.48 $3.75 $3.72 $3.70 $4.28 $3.88 $3.90 $3.87 $5.27 $3.75 $3.75 $3.82 $3.84 $3.92 $4.10 $4.20 $4.25 $4.36 $4.55 $5.70
FCF/Share $3.45 $3.95 $3.21 $3.29 $3.40 $4.10 $4.48 $4.54 $4.63 $6.69 $4.38 $4.47 $4.72 $4.70 $4.67 $4.39 $4.41 $4.56 $4.86 $5.34 $6.69
OCF/Share $3.45 $3.95 $3.21 $3.29 $3.40 $4.10 $4.48 $4.54 $4.63 $6.69 $4.38 $4.47 $4.72 $4.70 $4.67 $4.39 $4.41 $4.56 $4.86 $5.34 $6.69
Cash/Share $4.44 $5.49 $4.79 $5.60 $3.65 $4.65 $4.26 $4.80 $2.80 $2.76 $2.56 $4.28 $2.98 $3.01 $3.14 $2.65 $1.71 $1.14 $1.09 $1.50 $1.88
EBITDA/Share $2.93 $3.04 $2.54 $1.76 $1.57 $1.78 $1.95 $1.74 $1.69 $3.69 $2.02 $2.01 $3.24 $2.64 $3.49 $3.44 $2.83 $2.92 $3.04 $3.08 $3.08
Debt/Share $11.68 $13.89 $11.69 $11.70 $11.71 $13.62 $11.73 $11.76 $10.20 $13.74 $10.28 $12.74 $12.83 $12.92 $13.18 $14.24 $16.02 $15.99 $16.00 $16.09 $16.09
Net Debt/Share $7.24 $8.40 $6.90 $6.10 $8.06 $8.97 $7.47 $6.96 $7.40 $10.98 $7.71 $8.46 $9.85 $9.92 $10.04 $11.59 $14.31 $14.86 $14.92 $14.59 $14.59
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.465
Altman Z-Prime snapshot only 4.312
Piotroski F-Score 6 5 5 4 3 3 5 5 8 9 8 7 6 3 5 6 6 5 6 6 6
Beneish M-Score -1.75 -1.90 -2.40 -2.98 -3.05 -3.52 -3.58 -2.91 -3.23 -3.57 -3.49 -3.55 -3.43 -2.78 -2.98 -3.01 26.56 24.83 24.39 21.99 21.986
Ohlson O-Score snapshot only -8.454
ROIC (Greenblatt) snapshot only 9.45%
Net-Net WC snapshot only $-16.56
EVA snapshot only $85254500.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB-
Credit Score 66.79 62.81 67.49 63.35 57.06 54.52 57.74 58.52 61.67 68.28 63.55 59.35 64.42 51.89 63.91 59.67 60.32 50.87 61.59 54.07 54.072
Credit Grade snapshot only 10
Credit Trend snapshot only -5.599
Implied Spread (bps) snapshot only 350.000
Industry Credit Rank snapshot only 44
Sector Credit Rank snapshot only 48

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms